• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROLLENIUM MEDICAL TECHNOLOGIES INC. REVANESSE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROLLENIUM MEDICAL TECHNOLOGIES INC. REVANESSE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Obstruction/Occlusion (2422); Swelling/ Edema (4577)
Event Type  Injury  
Event Description
Based on the information provided, the patient got injected with revanesse dermal fillers in the upper left lip area of the patient on an unspecified date.The lot of the product injected was not provided and, therefore, not verified.According to the initial communication, amount of product injected was described as an extremely small amount of the filler into client's upper left vermillion boarder/cupid's bow with adverse issue no issue or reaction".Injector then went on to place filler in a thread like fashion in her left lower lip.After placement of filler in her left lower lip, the injector evaluated the left upper lip and noted an increased amount of swelling.Injector placed an ice pack over the lip with good response/decrease in swelling.Injector went on to complete her right lower lip, lower vermillion boarder, and right upper lip.There was an increase amount of swelling also noticed in the right lower lip.Injector placed ice over the entire lip with a good response and decrease in swelling.Injector then went back to evaluated the left upper lip.There was good capillary refill, pink color, and blood return when the lip was poked with a syringe.The patient had good sensation with minimal discomfort.Injector called local sales manager and was placed in contact with another area representative and informed him of situation.Injector immediately sought assistance from other medical professionals to assist in helping injector care for client and resolve her issue.Date of birth not provided.No information regarding topic anaesthetic has been provided.No information regarding allergies has been provided.No information regarding medical history and presence of risk factors have been provided.After follow up and assessing the patient the following day, the injector determined that patient had a vascular occlusion in the area of injection.Patient was treated with 25 vials of hylenex and now has capillary refill at approx.3 seconds with no reticularis noted and patient appears to be "normal" without tissue necrosis or vesicle formation since the day of notification, the qa department has attempted to contact the injector and clinic again to inquire additional information regarding the event, however no response has been received.As of (b)(6) 2022, no response from the clinic has been received.The qa department at prollenium medical technologies will continue the investigation.
 
Manufacturer Narrative
The clinical complaint is in the process of investigation.The lot number has not been verified due to the absence of information.It will be confirmed whether any clinical complaints have been found for the particular lot number in question once requested information is provided.The batch record, qc test reports, and training of staff will be analysed and be determined that product is within required specifications, and manufactured according to appropriate procedures once lot is verified.Prollenium medical technologies' medical director's response to this adverse event will be provided to the clinic along with the letter indicating approved areas for injection for revanesse versa+ and revanesse lips+ products when requested information for conducting investigation is provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVANESSE
Type of Device
REVANESSE
Manufacturer (Section D)
PROLLENIUM MEDICAL TECHNOLOGIES INC.
138 industrial parkway n,
aurora, on L4G 4 C3
CA  L4G 4C3
Manufacturer Contact
ario khoshbin
138 industrial parkway n
aurora, on L4G 4-C3
CA   L4G 4C3
MDR Report Key14836052
MDR Text Key295070693
Report Number3004423487-2022-00028
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P160042
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 06/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/01/2022
Initial Date FDA Received06/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-